HSKA — Heska Balance Sheet
0.000.00%
HealthcareAdventurousMid Cap
- $1.31bn
- $1.28bn
- $257.31m
Annual balance sheet for Heska, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 13.4 | 89 | 86.3 | 224 | 157 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 20.3 | 16.3 | 37.1 | 35.7 | 38.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 62.4 | 140 | 171 | 320 | 265 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 16 | 21.2 | 41 | 38.6 | 39.1 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 156 | 244 | 400 | 604 | 586 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.4 | 32.2 | 42.1 | 43.9 | 39.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 34 | 90.1 | 113 | 168 | 164 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 122 | 154 | 287 | 436 | 422 |
| Total Liabilities & Shareholders' Equity | 156 | 244 | 400 | 604 | 586 |
| Total Common Shares Outstanding |